Skip to main content

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

NDC 69097-209 · Cipla USA Inc.

Generic nameEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Strength200; 300 mg/1; mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
Marketing categoryANDA

Packages

69097-209-02 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-209-02)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65862-818 — Tenofovir Disoproxil Fumarate, 65862-819 — Tenofovir Disoproxil Fumarate, 65862-820 — Tenofovir Disoproxil Fumarate, 67296-2198 — Emtricitabine and tenofovir disoproxil fumarate, 68071-2112 — emtricitabine and tenofovir disoproxil fumarate, 68071-3695 — Emtricitabine and tenofovir disoproxil fumarate, 68071-3831 — Emtricitabine and tenofovir disoproxil fumarate, 68071-3986 — Emtricitabine and Tenofovir Disoproxil Fumarate, 68180-287 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, 69076-105 — Tenofovir Disoproxil Fumarate, 69097-210 — efavirenz, emtricitabine and tenofovir disoproxil fumarate, 69097-533 — Tenofovir disoproxil fumarate, 69097-642 — emtricitabine, 69097-741 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, 69238-2092 — Emtricitabine and Tenofovir Disoproxil Fumarate, 69238-2093 — Emtricitabine and Tenofovir Disoproxil Fumarate, 69238-2094 — Emtricitabine and Tenofovir Disoproxil Fumarate, 69238-2095 — Emtricitabine and Tenofovir Disoproxil Fumarate, 70710-1364 — Emtricitabine and tenofovir disoproxil fumarate, 70710-1365 — Emtricitabine and tenofovir disoproxil fumarate, +82 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels